ARCHIVES

FDA Approves Generic Version Of Capecitabine for Metastatic Colorectal and Breast Cancer

This article is from The Cancer Letter archive.

Vol. 36 No. 9 | September 27, 2013

Download PDF Visit The Full Archive

Related Articles

Advisors Voted For Provenge Approval Despite Fundamental Flaws In Trials.

April 13, 2007

Breast Density As Important As Age In Determining Risk

September 29, 2006

Funding Opportunities (8-page issue).

April 25, 2003

FDA To Regulate Products From Human Cells, Tissue

March 21, 1997

Cancer Cases To Double By 2050, Annual Report Says

May 31, 2002

DCT board Okays Recompetition of Clinical Trials Contracts

October 29, 1993